BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7684615)

  • 1. Generation and partial characterization of five monoclonal antibodies with high affinities for fibrin.
    Tymkewycz PM; Creighton Kempsford LJ; Gaffney PJ
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):211-21. PubMed ID: 7684615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
    Raut S; Gaffney PJ
    Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for fibrin specific monoclonal antibodies: the development of a new procedure.
    Tymkewycz PM; Creighton-Kempsford LJ; Hockley D; Gaffney PJ
    Thromb Haemost; 1992 Jul; 68(1):48-53. PubMed ID: 1514172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products.
    Chen F; Haber E; Matsueda GR
    Thromb Haemost; 1992 Mar; 67(3):335-40. PubMed ID: 1379385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of monoclonal antibodies for research on fibrin polymerization processes].
    Lugovskoĭ EV; Makogonenko EM; Chudnovets VS; Derzskaia SG; Gogolinskaia GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Liashko ED; Komissarenko SV
    Dokl Akad Nauk SSSR; 1991; 318(1):224-7. PubMed ID: 1716547
    [No Abstract]   [Full Text] [Related]  

  • 7. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The (DD)E complex is maintained by a composite fibrin polymerization site.
    Moskowitz KA; Budzynski AZ
    Biochemistry; 1994 Nov; 33(44):12937-44. PubMed ID: 7524657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neoantigenic determinant in coiled coil region of human fibrin beta-chain.
    Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Lugovskaya NE; Komisarenko SV
    Thromb Res; 2009 Mar; 123(5):765-70. PubMed ID: 18977516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A neoantigenic determinant in the D-dimer fragment of fibrin.
    Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo penetration of experimentally produced clots by monoclonal antibodies.
    McEvoy FJ; Edgell TA; Webbon PM; Gaffney PJ
    Thromb Haemost; 2000 Jun; 83(6):882-6. PubMed ID: 10896242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1984 Jan; 21(1):89-94. PubMed ID: 6200769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase.
    Charpie JR; Runge MS; Matsueda GR; Haber E
    Biochemistry; 1990 Jul; 29(27):6374-8. PubMed ID: 1698452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibility of epitopes on fibrin clots and fibrinogen gels.
    Procyk R; Kudryk B; Callender S; Blombäck B
    Blood; 1991 Apr; 77(7):1469-75. PubMed ID: 1706954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
    Hui KY; Haber E; Matsueda GR
    Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of fibrin polymerization with monoclonal antibodies.
    Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
    Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.